# In Vitro Activity of Tigecycline Among Key Bacterial Pathogens Exhibiting Multidrug Resistance

> **NCT01132417** · — · SUSPENDED · sponsor: **King Faisal University** · enrollment: 500 (estimated)

## Conditions studied

- Infections, Bacterial

## Interventions

- **DRUG:** In Vitro activity of Tigecycline among key bacterial pathogens exhibiting multidrug resistance

## Key facts

- **NCT ID:** NCT01132417
- **Lead sponsor:** King Faisal University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2009-09
- **Primary completion:** 2012-06
- **Final completion:** 2012-07
- **Target enrollment:** 500 (ESTIMATED)
- **Why stopped:** researchers delay
- **Last updated:** 2011-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01132417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01132417, "In Vitro Activity of Tigecycline Among Key Bacterial Pathogens Exhibiting Multidrug Resistance". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01132417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*